Literature DB >> 15462398

Clinical significance of cerebrovascular reserve in acetazolamide challenge -comparison with acetazolamide challenge H2O-PET and Gas-PET.

Masao Imaizumi1, Kazuo Kitagawa, Naohiko Oku, Kazuo Hashikawa, Masashi Takasawa, Takuya Yoshikawa, Yasuhiro Osaki, Kouji Matsushita, Masayasu Matsumoto, Masatsugu Hori, Jun Hatazawa.   

Abstract

OBJECTIVE: The response of cerebral blood flow (CBF) to acetazolamide (ACZ) challenge is frequently determined in clinical settings to evaluate cerebrovascular reserve (CVR). A reduced CVR can indicate patients with occlusive cerebrovascular disease and compromised hemodynamics who may be at increased risk of cerebral ischemia. However, how precisely ACZ reflects cerebral hemodynamic impairment remains obscure. The present study aims to clarify the pathological significance of CVR in patients with occluded carotid arteries.
METHODS: We recruited seventeen patients with occlusive lesions in the internal carotid artery (ICA) or middle cerebral artery (MCA). We assessed these patients in terms of resting cerebral blood flow (CBF) and the CVR response to ACZ challenge using H20 positron emission tomography (PET). In addition, we evaluated hemodynamic parameters including oxygen extraction fraction (OEF) using Gas-PET.
RESULTS: We identified a significant negative correlation between the CVR and OEF or the cerebral blood volume (CBV)/CBF ratio, as a potential index of cerebral perfusion pressure. Although the CVR values were reduced in all regions with elevated OEF (Stage II), these values were highly variable regardless of the CBV/CBF ratios. The cut-off value of CVR alone could not detect Stage II, but when combined with resting CBF, misery perfusion accompanied by increased OEF was detected with high sensitivity (6/7) and specificity (61/62).
CONCLUSION: CVR could be applied as an index reflecting both autoregulatory capacity and OEF. The present study also supported the notion that SPECT with ACZ challenge can be clinically applied to detect misery perfusion.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15462398     DOI: 10.1007/BF02984479

Source DB:  PubMed          Journal:  Ann Nucl Med        ISSN: 0914-7187            Impact factor:   2.668


  3 in total

1.  Paradoxical reduction of cerebral blood flow after acetazolamide loading: a hemodynamic and metabolic study with (15)O PET.

Authors:  Tadashi Watabe; Eku Shimosegawa; Hiroki Kato; Kayako Isohashi; Mana Ishibashi; Mitsuaki Tatsumi; Kazuo Kitagawa; Toshiyuki Fujinaka; Toshiki Yoshimine; Jun Hatazawa
Journal:  Neurosci Bull       Date:  2014-08-06       Impact factor: 5.203

Review 2.  MRI in the management of cerebrovascular disease to prevent stroke.

Authors:  Keith R Thulborn
Journal:  Neurol Clin       Date:  2008-11       Impact factor: 3.806

3.  Genetic enhancement of microsomal epoxide hydrolase improves metabolic detoxification but impairs cerebral blood flow regulation.

Authors:  Anne Marowsky; Karen Haenel; Ernesto Bockamp; Rosario Heck; Sibylle Rutishauser; Nandkishor Mule; Diana Kindler; Markus Rudin; Michael Arand
Journal:  Arch Toxicol       Date:  2016-02-02       Impact factor: 5.153

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.